176
Participants
Start Date
June 15, 2023
Primary Completion Date
March 31, 2026
Study Completion Date
May 31, 2026
Cholecalciferol
Patients in the intervention group will receive oral cholecalciferol 4000U per day.
Placebo
Patients in the control group will receive placebo 2 capsules per day.
RECRUITING
Peking University First Hospital, Beijing
Peking University Third Hospital
OTHER
Peking University People's Hospital
OTHER
Beijing Haidian Hospital
OTHER
Peking University Shenzhen Hospital
OTHER
Miyun District of Peking University First Hospital
UNKNOWN
Beijing Fangshan District Hospital of Traditional Chinese Medicine
UNKNOWN
Peking University International Hospital
OTHER
Beijing Tsinghua Changgeng Hospital
OTHER
Beijing Anzhen Hospital
OTHER
Capital Medical University
OTHER
Peking University First Hospital
OTHER